{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:01:40Z","timestamp":1761948100042},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0147173","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T20:58:02Z","timestamp":1453496282000},"page":"e0147173","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Arg-Gly-Asp (RGD)-Modified E1A\/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice"],"prefix":"10.1371","volume":"11","author":[{"given":"Yue-Hong","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Jian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Xing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"issue":"1","key":"ref1","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"RL Siegel","year":"2015","journal-title":"CA: a cancer journal for clinicians"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/aja.2008.21","article-title":"Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China","volume":"11","author":"L Zhang","year":"2009","journal-title":"Asian journal of andrology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"327253","DOI":"10.1155\/2012\/327253","article-title":"Castration-resistant prostate cancer: mechanisms, targets, and treatment","volume":"2012","author":"TM Amaral","year":"2012","journal-title":"Prostate cancer"},{"issue":"15","key":"ref4","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"IF Tannock","year":"2004","journal-title":"The New England journal of medicine"},{"issue":"13","key":"ref5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"HI Scher","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"21","key":"ref6","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"JS de Bono","year":"2011","journal-title":"The New England journal of medicine"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/hum.2013.229","article-title":"ORCA-010, a novel potency-enhanced oncolytic adenovirus, exerts strong antitumor activity in preclinical models","volume":"25","author":"W Dong","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/gt.2014.46","article-title":"Antitumor effects of oncolytic adenovirus armed with PSA-IZ-CD40L fusion gene against prostate cancer","volume":"21","author":"YF Yang","year":"2014","journal-title":"Gene Ther"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijrobp.2014.02.034","article-title":"Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer","volume":"89","author":"SO Freytag","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.urology.2007.09.031","article-title":"Oncolytic virotherapy for prostate cancer by E1A, E1B mutant adenovirus","volume":"70","author":"M Satoh","year":"2007","journal-title":"Urology"},{"issue":"3","key":"ref11","first-page":"813","article-title":"Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors","volume":"61","author":"JT Douglas","year":"2001","journal-title":"Cancer Res"},{"issue":"13","key":"ref12","first-page":"3812","article-title":"Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy","volume":"62","author":"KA Rauen","year":"2002","journal-title":"Cancer Res"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/bjc.2013.509","article-title":"Presence of the coxsackievirus and adenovirus receptor (CAR) in human neoplasms: a multitumour array analysis","volume":"109","author":"M Reeh","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.cgt.7700529","article-title":"Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer","volume":"10","author":"H Dehari","year":"2003","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/pros.2990230206","article-title":"p53 oncogene mutations in three human prostate cancer cell lines","volume":"23","author":"AG Carroll","year":"1993","journal-title":"The Prostate"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1098-2264(199706)19:2<90::AID-GCC4>3.0.CO;2-V","article-title":"Deletional, mutational, and methylation analyses of CDKN2 (p16\/MTS1) in primary and metastatic prostate cancer","volume":"19","author":"DF Jarrard","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/1078-0432.CCR-06-2103","article-title":"E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers","volume":"13","author":"M Wakayama","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"19","key":"ref18","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/nar\/23.19.3816","article-title":"Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase","volume":"23","author":"Y Kanegae","year":"1995","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"ref19","first-page":"4434","article-title":"E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer","volume":"63","author":"K Fukuda","year":"2003","journal-title":"Cancer Res"},{"issue":"19","key":"ref20","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1038\/sj.onc.1208460","article-title":"Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 (&apos;Telomelysin-RGD&apos;)","volume":"24","author":"M Taki","year":"2005","journal-title":"Oncogene"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.anndiagpath.2014.09.001","article-title":"Correlation between the expression of integrins in prostate cancer and clinical outcome in 1284 patients","volume":"18","author":"K Hess","year":"2014","journal-title":"Annals of diagnostic pathology"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/hum.2012.046","article-title":"Synergistic and Selective Cancer Cell Killing Mediated by the Oncolytic Adenoviral Mutant Ad\u0394\u0394 and Dietary Phytochemicals in Prostate Cancer Models","volume":"23","author":"V Adam","year":"2012","journal-title":"Hum Gene Ther"},{"issue":"7","key":"ref23","first-page":"1655","article-title":"Prostatic carcinomacell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway","volume":"59","author":"DQ Zheng","year":"1999","journal-title":"Cancer Res"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/80474","article-title":"An adenovirusE1A mutant that demonstrates potent and selective systemicanti-tumoral efficacy","volume":"6","author":"C Heise","year":"2000","journal-title":"Nat Med"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1128\/JVI.73.7.5333-5344.1999","article-title":"p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication","volume":"73","author":"JN Harada","year":"1999","journal-title":"J Virol"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/sj.onc.1207321","article-title":"A novel E1A-E1B mutant adenovirus induces glioma regression in vivo","volume":"23","author":"C Gomez-Manzano","year":"2004","journal-title":"Oncogene"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/ijc.26216","article-title":"Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors","volume":"130","author":"S Pesonen","year":"2012","journal-title":"Int J Cancer"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.4161\/cc.7.12.6166","article-title":"Targeting prostate cancer based on signal transduction and cell cycle pathways","volume":"7","author":"JT Lee","year":"2008","journal-title":"Cell cycle (Georgetown, Tex)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0147173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T08:34:23Z","timestamp":1600072463000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0147173"}},"subtitle":[],"editor":[{"given":"Ilya","family":"Ulasov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0147173","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,22]]}}}